Health Care/Hospital
Dymicron™ appoints Armen Khachatryan, M.D. to Board of Directors
OREM, Utah, Nov. 10, 2020 /PRNewswire/ -- Dymicron, a privately held, innovative medical device company developing a next generation cervical artificial disc, Triadyme-C™, with a proprietary polycrystalline diamond material and novel, Tri-Lobe articulating design, today announced thatArmen Khach...
Volition Veterinary Presents Expert Report Ahead of First Product Launch
* A Look to the Future of Cancer Diagnostics compiles insight from four veterinary cancer experts * Report provides insight into the clinical impact of early cancer detection, and recent advances * Experts also reviewed data on the Nu.Q™ Vet Cancer Screening Test, providing opinion and guid...
German MECOTEC Group launches one-stop-solution for deep-freeze, transport, storage and distribution for COVID-19-Vaccines with its first Mobile Hybrid Container
BITTERFELD-WOLFEN, Germany, Nov. 10, 2020 /PRNewswire/ -- Vaccine manufacturers, transport and storage providers are facing major challenges in the fight against the coronavirus. MECOTEC Group has announced a complete-one-stop-solution consisting of: 1. Deep-freeze cooling + 2. Transport + 3. St...
mdgroup Joins The Beryl Institute Community
LONDON, Nov. 10, 2020 /PRNewswire/ -- mdgroup, a global digital and patient services company, recently joined The Beryl Institute community as an organisational member. Organisational members create market distinction by supporting a culture where staff at all levels have access to patient exper...
Zymo Research Obtains CE IVD Mark for its Quick SARS-CoV-2 Multiplex Kit
Low cost, high-sensitivity diagnostic test for COVID-19 detection IRVINE, Calif., Nov. 10, 2020 /PRNewswire/ -- Zymo Research announced today that it obtained a CE IVD mark for theQuick SARS-CoV-2 Multiplex Kit in compliance with the Directive 98/79/EC of the European Parliament and of the Counc...
Inspiration Capital Partners becomes a strategic investor of New Frontier Vitality
HONG KONG, Nov. 10, 2020 /PRNewswire/ -- Inspiration Capital Partners ("ICP") today announced that private equity funds advised by ICP have become strategic capital partners and investors of New Frontier Vitality ("NFV"), the leading integrated post-acute and geriatric healthcare platform inChina...
Swiss Rockets AG announces the founding of ROCKETVAX for the development of a next-generation SARS-CoV-2 vaccine
BASEL, Switzerland, Nov. 10, 2020 /PRNewswire/ -- The rapid development of an effective and safe vaccine against SARS-CoV-2 is a top priority for Swiss Rockets AG. ABasel-based subsidiary, RocketVax AG, was founded to utilize innovative Swiss technologies and expertise to achieve this goal. "The...
Insilico announces a multi-target AI-powered drug discovery collaboration with Janssen
BEIJING, Nov. 10, 2020 /PRNewswire/ -- Insilico Medicine, a leader in deep generative reinforcement learning for target discovery, small molecule generation, and prediction of clinical trial outcomes, today announced that it entered into a multi-target drug discovery agreement with Janssen Pharma...
Farrer Park Hospital Steps Up Prostate Cancer Treatment with Lutetium-177 PSMA Therapy
SINGAPORE, Nov. 10, 2020 /PRNewswire/ -- Farrer Park Hospital
I-Mab Reports Phase 1 Clinical Trial Data of Highly Differentiated Anti-CD47 Monoclonal Antibody Lemzoparlimab at the 2020 SITC Annual Meeting
SHANGHAI and GAITHERSBURG, Md., Nov. 9, 2020 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced initial results from its U.S. phase 1 clinical trial (NCT...
Connect Biopharma to Present at the Jefferies Virtual London Healthcare Conference on November 17, 2020
SAN DIEGO and TAICANG, SUZHOU, China, Nov. 9, 2020 /PRNewswire/ -- Connect Biopharma, a clinical-stage biopharmaceutical company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune and inflammatory diseases, today announced thatZhe...
Merck Announces Out-Licensing Agreement for Investigational Atacicept with Vera Therapeutics
Not intended for UK and US based media - Merck out-licenses Phase IIb-ready atacicept to Vera Therapeutics - Phase IIa trial conducted by Merck shows promising results in IgA nephropathy (IgAN), also known as "Berger's disease" - Out-licencing deal includes 10% equity in Vera Therapeutics and up...
VolitionRx Limited Schedules Third Quarter 2020 Earnings Conference Call and Business Update
AUSTIN, Texas, Nov. 9, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced it will host a conference call onFriday, November 13, at 8:30 a.m. Eastern time to discuss its financial and operating results for the third quarter 2020, in addition to providing a b...
Pierre Fabre initiates a "First in Human" clinical trial for an innovative monoclonal antibody (W0180) targeting the VISTA checkpoint in patients with solid tumors
TOULOUSE, France, Nov. 9, 2020 /PRNewswire/ -- Pierre Fabre announced today the initiation of an international Phase I clinical study in patients with relapsed or refractory solid tumors for its investigational product W0180, an innovative monoclonal antibody targeting VISTA, developed by Pierre ...
GenScript Receives FDA Emergency Use Authorization for World's First SARS-CoV-2 Neutralizing Antibody Detection Kit
PISCATAWAY, N.J., Nov. 9, 2020 /PRNewswire/ -- GenScript USA Inc., the world's
leading research reagent provider, announced today that the U.S. Food and Drug
Administration (FDA) has grantedEmergency Use Authorization (EUA)
FTLife Launches "HealthCare 168 Plus" Critical Illness Protector
HONG KONG, Nov. 9, 2020 /PRNewswire/ -- FTLife Insurance Company Limited ("FTLife") today announced the launch of "HealthCare 168 Plus" Critical Illness Protector ("HealthCare 168 Plus" or "the Plan"), aggregated with two first-in-market[1] features including additional monthly financial support ...
OrbusNeich® Medical and P+F Products & Features® announce new partnership
Introducing a new portfolio of heart valve products aiming to restore health and extend life HONG KONG, Nov. 9, 2020 /PRNewswire/ -- OrbusNeich and P+F today announced they have entered into an agreement for the exclusive distribution and manufacturing of a range of innovative minimally invasive...
The world's largest RCT investigating use of MagicTouch PTA Sirolimus Coated balloon for peripheral artery disease kicks off to a flying start
ZÜRICH, Nov. 9, 2020 /PRNewswire/ -- Concept Medical Inc.,
TaiGen Partners with GPCR to develop Burixafor & Taigexyn(R)
TAIPEI, Nov. 9, 2020 /PRNewswire/ -- TaiGen Biotechnology Company, Limited ("TaiGen") announced today that they have signed an exclusive agreement with GPCR Therapeutics, Inc. ("GPCR"), a leading Korean biotechnology company, for the continued development of Burixafor worldwide and the commercial...
Termination of Bridge Biotherapeutics's Collaboration and License Agreement with Boehringer Ingelheim
SEONGNAM, South Korea, Nov. 9, 2020 /PRNewswire/ -- On November 9, 2020, Bridge Biotherapeutics (288330 KQ) reported to the Korea Stock Exchange that the Company and Boehringer Ingelheim have mutually agreed on the termination of the Collaboration and License Agreement entered into inJuly 2019 to...
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 294 media titles]
2024-04-22 16:00Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 291 media titles]
2024-04-22 06:00With unique features, Hainan TV opened "The World's Specialty" pavilion at the Expo!
[Picked up by 287 media titles]
2024-04-18 21:26China's Yiwu Establishes Welcoming Committee to Attract International Buyers
[Picked up by 286 media titles]
2024-04-19 13:25Animated Life in Yunnan
[Picked up by 281 media titles]
2024-04-18 14:00